Table 2.
The correlation between lncRNA HAGLROS expression and clinicopathological features (n = 54).
| Clinical features | N | lncRNA HAGLROS expression |
Chi-square value | p value | |
|---|---|---|---|---|---|
| High expression | Low expression | ||||
| Age | |||||
| >60 | 22 | 14 | 8 | 0.1534 | 0.6953 |
| ≤60 | 32 | 22 | 10 | ||
| Gender | |||||
| Male | 31 | 21 | 10 | 0.0379 | 0.8457 |
| Female | 23 | 15 | 8 | ||
| Smoking history | |||||
| Smoker | 29 | 19 | 10 | 0.0372 | 0.8470 |
| Non-smoker | 25 | 17 | 8 | ||
| T stage | |||||
| T1-T2 | 7 | 2 | 5 | 0.034 | |
| T3-T4 | 47 | 34 | 13 | ||
| Lymph invasion | |||||
| N0 | 24 | 11 | 13 | 8.4375 | 0.0037 |
| N1–N2 | 30 | 25 | 5 | ||
| Histology | |||||
| Squamous cancer | 16 | 10 | 6 | 1.0000 | 0.6065 |
| Adenocarcinoma | 20 | 15 | 5 | ||
| Large cell carcinoma | 18 | 11 | 7 | ||